Annette W. Dahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Annette W. Dahl has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Otto Robertsson
The Swedish Knee Arthroplasty Register, Department of Orthopedics, Skane University Hospital, Lund, Sweden, and Department of Clinical Sciences, Orthopedics, Lund University, Sweden
8 shared publications - Alma Becic Pedersen
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
6 shared publications - Anne Marie Fenstad
The Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University Hospital, Bergen, Norway
6 shared publications - Ola Rolfson
Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
6 shared publications Otto Robertsson
A The Swedish Knee Arthroplasty Register
5 shared publications- Ove Furnes
Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway
5 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 329–335
Patient injuries after total hip arthroplasty for osteoarthritis in Sweden over 10 years: a cohort study based on 1,343 patients
Background and purpose: Injuries after primary total hip arthroplasty (THA) can be compensated through the National Swedish Patient Insurance Company (Löf). This study examined injury incidence, types, consequences, and subgroup differences in compensated claims following primary THA for osteoarthritis (OA) in Sweden over 10 years.Methods: Data from Löf and the Swedish Arthroplasty Register were used for compensated claims following primary THA between 2012 and 2021. Injury incidence and subgroup differences by sex, age, OA diagnosis, and surgical volume were analyzed. Injury types, severity, reoperation rate, and surgical approach were evaluated. Absolute risk differences (ARD) and incidence rate ratios (IRR) were calculated.Results: 1,343 injuries were followed up. The injury incidence was 1.3%. Injury rates were higher in patients < 65 years than ≥ 65 years (ARD 0.2%, 95% confidence interval [CI] 0.1–0.3), in OA due to hip dysplasia compared with primary OA (IRR 1.78, CI 1.31–2.35), and at low- and medium-volume compared with high-volume hospitals (IRR 1.35, CI 1.11–1.64; IRR 1.27, CI 1.14–1.42). In surgery-related injuries (n = 1,251), infection (38%, CI 35–41) and nerve injury (22%, CI 20–25) were the most common injury types, and direct lateral incisions were more frequent than national reference proportions of all THAs during the study period (ARD 9%, CI 6–12). Permanent disability occurred in 74% (CI 72–77) of the claims, and the 2-year reoperation rate was 51% (CI 48–54) (0.4% of the total population).Conclusion: The injury incidence after primary THA was 1.3% and frequently resulted in permanent disability and reoperation. Infection and nerve injury were the most common injury types. Higher injury rates in younger patients, hip dysplasia, and lower-volume hospitals highlight potential areas for prevention and increased awareness.
- 4 June 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 329–335
Open AccessPatient injuries after total hip arthroplasty for osteoarthritis in Sweden over 10 years: a cohort study based on 1,343 patients
Background and purpose: Injuries after primary total hip arthroplasty (THA) can be compensated through the National Swedish Patient Insurance Company (Löf). This study examined injury incidence, types, consequences, and subgroup differences in compensated claims following primary THA for osteoarthritis (OA) in Sweden over 10 years.Methods: Data from Löf and the Swedish Arthroplasty Register were used for compensated claims following primary THA between 2012 and 2021. Injury incidence and subgroup differences by sex, age, OA diagnosis, and surgical volume were analyzed. Injury types, severity, reoperation rate, and surgical approach were evaluated. Absolute risk differences (ARD) and incidence rate ratios (IRR) were calculated.Results: 1,343 injuries were followed up. The injury incidence was 1.3%. Injury rates were higher in patients < 65 years than ≥ 65 years (ARD 0.2%, 95% confidence interval [CI] 0.1–0.3), in OA due to hip dysplasia compared with primary OA (IRR 1.78, CI 1.31–2.35), and at low- and medium-volume compared with high-volume hospitals (IRR 1.35, CI 1.11–1.64; IRR 1.27, CI 1.14–1.42). In surgery-related injuries (n = 1,251), infection (38%, CI 35–41) and nerve injury (22%, CI 20–25) were the most common injury types, and direct lateral incisions were more frequent than national reference proportions of all THAs during the study period (ARD 9%, CI 6–12). Permanent disability occurred in 74% (CI 72–77) of the claims, and the 2-year reoperation rate was 51% (CI 48–54) (0.4% of the total population).Conclusion: The injury incidence after primary THA was 1.3% and frequently resulted in permanent disability and reoperation. Infection and nerve injury were the most common injury types. Higher injury rates in younger patients, hip dysplasia, and lower-volume hospitals highlight potential areas for prevention and increased awareness.
- Open Access
- 20 March 2026
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (7) , 1315-1327
Acute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register
Background: Acute TKA has been proposed as an alternative to open reduction and internal fixation for complex tibial plateau fractures in patients who are older and who have compromised bone quality. The alternative is a delayed TKA after primary fracture management with an unfavorable outcome. However, the long-term outcomes and risk for reoperation after acute TKA compared with delayed TKA for fracture sequelae remain unclear. Questions/purposes: When comparing acute TKA (< 3 months after injury) for tibial plateau fracture with delayed TKA for fracture sequelae, we asked: (1) Do the risks of reoperation or revision for any cause differ? (2) Do the risks of reoperation or revision for infection differ? (3) Do the risks of reoperation or revision for loosening differ? Methods: Data for all TKAs performed between 2014 and 2023 with the indication of acute tibial plateau fracture (n = 152) or fracture sequelae (n = 950) were extracted from the Swedish Arthroplasty Register. Patients who underwent TKA for acute tibial plateau fractures were older (73 versus 66 years), more often women (78% [118 of 152] versus 57% [539 of 950]), had lower BMI (26.7 versus 27.9 kg/m 2 ), and received constrained or hinged implants more frequently (59% [89 of 152] versus 33% [311 of 950]). Reoperations were identified in the Swedish Arthroplasty Register through subsequent procedures on the index knee and classified as reoperations (where the implant remained in situ) or revisions (with exchange, addition, or removal of components). When bilateral procedures occurred within the study period, only the first TKA was retained to ensure independence of observations. Loss to follow-up because of emigration or incomplete revision reporting was expected to be minimal, as the Swedish Arthroplasty Register captures approximately 98% of primary TKAs and 94% of revisions nationally. We estimated the cumulative event probability of secondary procedures using the Kaplan-Meier method and used logistic regression models to estimate adjusted ORs for (1) any reoperation or revision, (2) infection-related procedures, and (3) loosening-related procedures, adjusting for age, gender, and BMI. Because implant type reflects the underlying clinical situation and cannot be reliably adjusted for, it was reported descriptively. Results: During follow-up, 7% (78 of 1102) of patients underwent a reoperation and 5% (60 of 1102) of patients underwent a revision. At 5 years, the cumulative event probability of any revision was 8% (95% confidence interval [CI] 2% to 14%) for acute TKA and 5% (95% CI 4% to 7%) for delayed TKA (p = 0.41). For reoperations, the cumulative event probability at 5 years was 9% (95% CI 3% to 15%) for acute TKA and 7% (95% CI 5% to 9%) in the delayed TKA group (p = 0.26). After adjusting for age, gender, and BMI, there was no difference between groups in odds for any reoperation (OR 0.76 [95% CI 0.38 to 1.5]; p = 0.43) or any revision (OR 0.68 [95% CI 0.31 to 1.5]; p = 0.32). Infections accounted for 9% (1 of 11) of reoperations for acute TKAs and 40% (27 of 67) of delayed TKAs. At 5 years, the cumulative event probability of reoperation or revision due to infection was 2% (95% CI 0% to 5%) for acute TKA and 3% (95% CI 2% to 4%) for delayed TKA (p = 0.06). There was no difference in the adjusted odds of infection-related reoperation (OR 3.7 [95% CI 0.48 to 28]; p = 0.21) or infection-related revision (OR 3.0 [95% CI 0.40 to 23]; p = 0.28). Loosening accounted for 27% (3 of 11) of revisions after acute TKAs and 9% (6 of 67) after delayed TKAs. At 5 years, the cumulative event probability of loosening-related revision was 2.9% (95% CI 0% to 7.1%) for acute TKAs and 0.6% (95% CI 0.1% to 1.2%) for delayed TKAs (p = 0.50). The adjusted odds of loosening-related revision were lower for delayed TKAs (OR 0.21 [95% CI 0.05 to 0.97]; p = 0.045). Conclusion: The timing and pattern of revision differ between the two investigated groups, with delayed TKAs undergoing unplanned reoperation or revision earlier and with a higher proportion of infection-related revisions, whereas acute TKAs underwent reoperation or revision later and with a higher proportion of revisions for mechanical loosening. In the absence of large prospective trials, future observational work should include evaluation of pre- and postoperative radiographs and patient-reported outcomes, to determine which patients may benefit from acute TKA for tibial plateau fracture. Level of Evidence: Level III, therapeutic study.
- 20 March 2026
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (7) , 1315-1327
Open AccessAcute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register
Background: Acute TKA has been proposed as an alternative to open reduction and internal fixation for complex tibial plateau fractures in patients who are older and who have compromised bone quality. The alternative is a delayed TKA after primary fracture management with an unfavorable outcome. However, the long-term outcomes and risk for reoperation after acute TKA compared with delayed TKA for fracture sequelae remain unclear. Questions/purposes: When comparing acute TKA (< 3 months after injury) for tibial plateau fracture with delayed TKA for fracture sequelae, we asked: (1) Do the risks of reoperation or revision for any cause differ? (2) Do the risks of reoperation or revision for infection differ? (3) Do the risks of reoperation or revision for loosening differ? Methods: Data for all TKAs performed between 2014 and 2023 with the indication of acute tibial plateau fracture (n = 152) or fracture sequelae (n = 950) were extracted from the Swedish Arthroplasty Register. Patients who underwent TKA for acute tibial plateau fractures were older (73 versus 66 years), more often women (78% [118 of 152] versus 57% [539 of 950]), had lower BMI (26.7 versus 27.9 kg/m 2 ), and received constrained or hinged implants more frequently (59% [89 of 152] versus 33% [311 of 950]). Reoperations were identified in the Swedish Arthroplasty Register through subsequent procedures on the index knee and classified as reoperations (where the implant remained in situ) or revisions (with exchange, addition, or removal of components). When bilateral procedures occurred within the study period, only the first TKA was retained to ensure independence of observations. Loss to follow-up because of emigration or incomplete revision reporting was expected to be minimal, as the Swedish Arthroplasty Register captures approximately 98% of primary TKAs and 94% of revisions nationally. We estimated the cumulative event probability of secondary procedures using the Kaplan-Meier method and used logistic regression models to estimate adjusted ORs for (1) any reoperation or revision, (2) infection-related procedures, and (3) loosening-related procedures, adjusting for age, gender, and BMI. Because implant type reflects the underlying clinical situation and cannot be reliably adjusted for, it was reported descriptively. Results: During follow-up, 7% (78 of 1102) of patients underwent a reoperation and 5% (60 of 1102) of patients underwent a revision. At 5 years, the cumulative event probability of any revision was 8% (95% confidence interval [CI] 2% to 14%) for acute TKA and 5% (95% CI 4% to 7%) for delayed TKA (p = 0.41). For reoperations, the cumulative event probability at 5 years was 9% (95% CI 3% to 15%) for acute TKA and 7% (95% CI 5% to 9%) in the delayed TKA group (p = 0.26). After adjusting for age, gender, and BMI, there was no difference between groups in odds for any reoperation (OR 0.76 [95% CI 0.38 to 1.5]; p = 0.43) or any revision (OR 0.68 [95% CI 0.31 to 1.5]; p = 0.32). Infections accounted for 9% (1 of 11) of reoperations for acute TKAs and 40% (27 of 67) of delayed TKAs. At 5 years, the cumulative event probability of reoperation or revision due to infection was 2% (95% CI 0% to 5%) for acute TKA and 3% (95% CI 2% to 4%) for delayed TKA (p = 0.06). There was no difference in the adjusted odds of infection-related reoperation (OR 3.7 [95% CI 0.48 to 28]; p = 0.21) or infection-related revision (OR 3.0 [95% CI 0.40 to 23]; p = 0.28). Loosening accounted for 27% (3 of 11) of revisions after acute TKAs and 9% (6 of 67) after delayed TKAs. At 5 years, the cumulative event probability of loosening-related revision was 2.9% (95% CI 0% to 7.1%) for acute TKAs and 0.6% (95% CI 0.1% to 1.2%) for delayed TKAs (p = 0.50). The adjusted odds of loosening-related revision were lower for delayed TKAs (OR 0.21 [95% CI 0.05 to 0.97]; p = 0.045). Conclusion: The timing and pattern of revision differ between the two investigated groups, with delayed TKAs undergoing unplanned reoperation or revision earlier and with a higher proportion of infection-related revisions, whereas acute TKAs underwent reoperation or revision later and with a higher proportion of revisions for mechanical loosening. In the absence of large prospective trials, future observational work should include evaluation of pre- and postoperative radiographs and patient-reported outcomes, to determine which patients may benefit from acute TKA for tibial plateau fracture. Level of Evidence: Level III, therapeutic study.
- Open Access
- 23 January 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 53-59
The risk of revision using tourniquet or not in primary total knee replacement: an observational study from the Swedish Knee Arthroplasty Register
Background and purpose: The use of a tourniquet in knee replacement surgery is debated. Given the conflicting evidence, we aimed to compare the risk of revision after total knee replacements (TKR) with or without the use of tourniquet.Methods: In this register based observational study, we included the 5 most common cemented primary TKR models due to osteoarthritis reported to the Swedish Arthroplasty Register 2010–2024 and followed them until December 31, 2024. The first revision for implant loosening was the primary outcome. We estimated the cumulative revision rate (CRR) with 95% confidence interval (CI) using the 1–Kaplan–Meier method. We examined the use of a tourniquet regarding the risk of revision using multiple Cox regression analysis to calculate the hazard ratio (HR) with CI and adjusted for potential confounding factors.Results: Of the 149,616 TKRs included, 65,570 (44%) were with tourniquet and 84,046 (56%) without tourniquet. The CRR was similar at all time-points for all causes and infection; however, CRR started to increase at 6–7 years for implant loosening with use of a tourniquet. In the Cox regression analysis, the use of a. tourniquet was associated with an increased risk of revision for implant loosening after 5 years (HR 1.56, CI 1.06–2.30). There was no difference in revision for all causes (HR 1.07, CI 0.99–1.15) or infection (HR 1.08, CI 0.97–1.21).Conclusion: The use of a tourniquet was associated with an increased risk of revision for implant loosening after 5 years, while no association was found for all-cause revision or infection. Our results do not support the use of a tourniquet in TKR as a strategy to reduce the risk of revision, either due to all causes, implant loosening, or infection.
- 23 January 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 53-59
Open AccessThe risk of revision using tourniquet or not in primary total knee replacement: an observational study from the Swedish Knee Arthroplasty Register
Background and purpose: The use of a tourniquet in knee replacement surgery is debated. Given the conflicting evidence, we aimed to compare the risk of revision after total knee replacements (TKR) with or without the use of tourniquet.Methods: In this register based observational study, we included the 5 most common cemented primary TKR models due to osteoarthritis reported to the Swedish Arthroplasty Register 2010–2024 and followed them until December 31, 2024. The first revision for implant loosening was the primary outcome. We estimated the cumulative revision rate (CRR) with 95% confidence interval (CI) using the 1–Kaplan–Meier method. We examined the use of a tourniquet regarding the risk of revision using multiple Cox regression analysis to calculate the hazard ratio (HR) with CI and adjusted for potential confounding factors.Results: Of the 149,616 TKRs included, 65,570 (44%) were with tourniquet and 84,046 (56%) without tourniquet. The CRR was similar at all time-points for all causes and infection; however, CRR started to increase at 6–7 years for implant loosening with use of a tourniquet. In the Cox regression analysis, the use of a. tourniquet was associated with an increased risk of revision for implant loosening after 5 years (HR 1.56, CI 1.06–2.30). There was no difference in revision for all causes (HR 1.07, CI 0.99–1.15) or infection (HR 1.08, CI 0.97–1.21).Conclusion: The use of a tourniquet was associated with an increased risk of revision for implant loosening after 5 years, while no association was found for all-cause revision or infection. Our results do not support the use of a tourniquet in TKR as a strategy to reduce the risk of revision, either due to all causes, implant loosening, or infection.
- Open Access
- 10 November 2025
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 96, 834–835
Erratum: Incidence of constrained condylar and hinged knee implants and mid- to long-term survivorship: a register-based study from the Nordic Arthroplasty Register Association (NARA)
Is missing (Erratum) This Erratum relates to the following article:https://doi.org/10.2340/17453674.2025.42999
- 10 November 2025
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 96, 834–835
Open AccessErratum: Incidence of constrained condylar and hinged knee implants and mid- to long-term survivorship: a register-based study from the Nordic Arthroplasty Register Association (NARA)
Is missing (Erratum) This Erratum relates to the following article:https://doi.org/10.2340/17453674.2025.42999
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (3)
Antibiotic-Loaded Bone Cement and Risk of Infection After Knee Arthroplasty in High-Risk Patients
Background: The use of antibiotic-loaded bone cement (ALBC) in primary total knee arthroplasty (TKA) is debated. Some argue that ALBC might only be justified in high-risk patients. This study assessed the effectiveness of ALBC vs. plain bone cement (PBC) in reducing risk of revision for periprosthetic joint infection (PJI) in TKA patients considered to have a high risk of infection. Methods: Cohort study of primary TKAs in 11 national or regional arthroplasty registries from 2010 to 2020. The 1-year risk of revision for PJI in TKAs with ALBC vs. PBC among patients with high American Society of Anesthesiologists (ASA) classification, body mass index (BMI), and/or diabetes was compared. Cumulative percent revision (1 minus Kaplan-Meier) based on 685,818 TKAs and Cox regression analyses (adjusted Hazard Rate Ratios [aHRRs]) were performed for TKAs with ALBC (reference) vs. PBC restricted to the following high-risk subgroups of patients: (1) ASA ≥3 (n = 335,612 vs. 35,997), (2) BMI ≥35 (n = 278,927 vs. 24,737), (3) ASA ≥3 and BMI ≥35 (n = 99,407 vs. 11,407), (4) diabetes (n = 38,341 vs. 21,838), and (5) ASA ≥3, BMI ≥35, and diabetes (n = 3,347 vs. 4,261). Advanced distributed meta-analyses were performed to combine all aggregate data and assess 1-year risk of revision for PJI. Results: Each registry reported a 1-year cumulative percent revision of ≤1.6% for PJI following TKAs both for ALBC and PBC in all high-risk subgroups. Similar 1-year risks of revision for PJI were found in TKAs with ALBC (reference) and PBC among patients with ASA ≥3 (aHRR: 1.09; 95% CI, 0.90-1.31); BMI ≥35 (1.06; 0.54-2.12); ASA ≥3 and BMI ≥35 (1.12; 0.83-1.50); diabetes (0.95; 0.74-1.20); and ASA ≥3, BMI ≥35, and diabetes (1.40; 0.86-2.29). Conclusions and Relevance: Similar 1-year revision risk of PJI was found for TKAs with ALBC vs. PBC in high-risk patients. Confirmation of the efficacy of ALBC in high-risk TKA patients needs to be evaluated in clinical trials. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 July 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (3)
Open AccessAntibiotic-Loaded Bone Cement and Risk of Infection After Knee Arthroplasty in High-Risk Patients
Background: The use of antibiotic-loaded bone cement (ALBC) in primary total knee arthroplasty (TKA) is debated. Some argue that ALBC might only be justified in high-risk patients. This study assessed the effectiveness of ALBC vs. plain bone cement (PBC) in reducing risk of revision for periprosthetic joint infection (PJI) in TKA patients considered to have a high risk of infection. Methods: Cohort study of primary TKAs in 11 national or regional arthroplasty registries from 2010 to 2020. The 1-year risk of revision for PJI in TKAs with ALBC vs. PBC among patients with high American Society of Anesthesiologists (ASA) classification, body mass index (BMI), and/or diabetes was compared. Cumulative percent revision (1 minus Kaplan-Meier) based on 685,818 TKAs and Cox regression analyses (adjusted Hazard Rate Ratios [aHRRs]) were performed for TKAs with ALBC (reference) vs. PBC restricted to the following high-risk subgroups of patients: (1) ASA ≥3 (n = 335,612 vs. 35,997), (2) BMI ≥35 (n = 278,927 vs. 24,737), (3) ASA ≥3 and BMI ≥35 (n = 99,407 vs. 11,407), (4) diabetes (n = 38,341 vs. 21,838), and (5) ASA ≥3, BMI ≥35, and diabetes (n = 3,347 vs. 4,261). Advanced distributed meta-analyses were performed to combine all aggregate data and assess 1-year risk of revision for PJI. Results: Each registry reported a 1-year cumulative percent revision of ≤1.6% for PJI following TKAs both for ALBC and PBC in all high-risk subgroups. Similar 1-year risks of revision for PJI were found in TKAs with ALBC (reference) and PBC among patients with ASA ≥3 (aHRR: 1.09; 95% CI, 0.90-1.31); BMI ≥35 (1.06; 0.54-2.12); ASA ≥3 and BMI ≥35 (1.12; 0.83-1.50); diabetes (0.95; 0.74-1.20); and ASA ≥3, BMI ≥35, and diabetes (1.40; 0.86-2.29). Conclusions and Relevance: Similar 1-year revision risk of PJI was found for TKAs with ALBC vs. PBC in high-risk patients. Confirmation of the efficacy of ALBC in high-risk TKA patients needs to be evaluated in clinical trials. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 6 February 2025
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 96, 142–150
Incidence of constrained condylar and hinged knee implants and mid- to long-term survivorship: a register-based study from the Nordic Arthroplasty Register Association (NARA)
Background and purpose: In complex primary total knee arthroplasty (TKA), constrained condylar knee (CCK) or rotating hinge knee (RHK) designs may be required to provide stability or address bony deficiencies. We analyzed trends in incidence of these designs in primary TKA and evaluated the mid- to long-term survivorship of CCK and RHK in 4 Nordic countries.Methods: From 2000 to 2017, 5,134 CCK and 2,515 RHK primary TKAs were identified from the NARA database. Kaplan–Meier (K–M) survival and flexible parametric survival model (FPSM) analyses were performed to estimate revision risk, expressed as hazard ratio (HR) with 95% confidence intervals (CI), with minimally stabilized (MS) TKA acting as the control group (n = 456,137).Results: The incidence of CCK and RHK implants increased significantly in Finland, while it was moderate in Denmark, Norway, and Sweden. With revision for any reason as the endpoint the 15-year K–M cumulative revision risk for RHK was 13.6% (CI 10.4–16.7) and for CCK it was 11.3% (CI 9.1–13.5). Compared with MS TKA, the hazard ratio for revision was 2.1 (CI 1.8–2.3) for CCK and 2.5 (CI 2.1–2.8) for RHK. Periprosthetic joint infection (PJI) was the most common reason for revision, accounting for 44% of CCK and 47% of RHK cases. After excluding revisions for PJI, the hazard ratio remained high for both designs, at 1.5 (CI 1.3–1.7) for CCK and 1.6 (CI 1.3–2.0) for RHK compared with MS.Conclusion: The incidence of CCK and RHK increased during the study period. Both designs showed consistent 15-year revision risks of 11–14%, with no major differences between them. The higher revision risk compared with MS TKAs may reflect the complexity of the surgeries.
- 6 February 2025
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 96, 142–150
Open AccessIncidence of constrained condylar and hinged knee implants and mid- to long-term survivorship: a register-based study from the Nordic Arthroplasty Register Association (NARA)
Background and purpose: In complex primary total knee arthroplasty (TKA), constrained condylar knee (CCK) or rotating hinge knee (RHK) designs may be required to provide stability or address bony deficiencies. We analyzed trends in incidence of these designs in primary TKA and evaluated the mid- to long-term survivorship of CCK and RHK in 4 Nordic countries.Methods: From 2000 to 2017, 5,134 CCK and 2,515 RHK primary TKAs were identified from the NARA database. Kaplan–Meier (K–M) survival and flexible parametric survival model (FPSM) analyses were performed to estimate revision risk, expressed as hazard ratio (HR) with 95% confidence intervals (CI), with minimally stabilized (MS) TKA acting as the control group (n = 456,137).Results: The incidence of CCK and RHK implants increased significantly in Finland, while it was moderate in Denmark, Norway, and Sweden. With revision for any reason as the endpoint the 15-year K–M cumulative revision risk for RHK was 13.6% (CI 10.4–16.7) and for CCK it was 11.3% (CI 9.1–13.5). Compared with MS TKA, the hazard ratio for revision was 2.1 (CI 1.8–2.3) for CCK and 2.5 (CI 2.1–2.8) for RHK. Periprosthetic joint infection (PJI) was the most common reason for revision, accounting for 44% of CCK and 47% of RHK cases. After excluding revisions for PJI, the hazard ratio remained high for both designs, at 1.5 (CI 1.3–1.7) for CCK and 1.6 (CI 1.3–2.0) for RHK compared with MS.Conclusion: The incidence of CCK and RHK increased during the study period. Both designs showed consistent 15-year revision risks of 11–14%, with no major differences between them. The higher revision risk compared with MS TKAs may reflect the complexity of the surgeries.
- Open Access
- 9 August 2023
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 94, 416-425
The use of antibiotic-loaded bone cement and systemic antibiotic prophylactic use in 2,971,357 primary total knee arthroplasties from 2010 to 2020: an international register-based observational study among countries in Africa, Europe, North America, and Oceania
Background and purpose: Antibiotic-loaded bone cement (ALBC) and systemic antibiotic prophylaxis (SAP) have been used to reduce periprosthetic joint infection (PJI) rates. We investigated the use of ALBC and SAP in primary total knee arthroplasty (TKA).Patients and methods: This observational study is based on 2,971,357 primary TKAs reported in 2010–2020 to national/regional joint arthroplasty registries in Australia, Denmark, Finland, Germany, Italy, the Netherlands, New Zealand, Norway, Romania, South Africa, Sweden, Switzerland, the UK, and the USA. Aggregate-level data on trends and types of bone cement, antibiotic agents, and doses and duration of SAP used was extracted from participating registries.Results: ALBC was used in 77% of the TKAs with variation ranging from 100% in Norway to 31% in the USA. Palacos R+G was the most common (62%) ALBC type used. The primary antibiotic used in ALBC was gentamicin (94%). Use of ALBC in combination with SAP was common practice (77%). Cefazolin was the most common (32%) SAP agent. The doses and duration of SAP used varied from one single preoperative dosage as standard practice in Bolzano, Italy (98%) to 1-day 4 doses in Norway (83% of the 40,709 TKAs reported to the Norwegian arthroplasty register).Conclusion: The proportion of ALBC usage in primary TKA varies internationally, with gentamicin being the most common antibiotic. ALBC in combination with SAP was common practice, with cefazolin the most common SAP agent. The type of ALBC and type, dose, and duration of SAP varied among participating countries.
- 9 August 2023
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 94, 416-425
Open AccessThe use of antibiotic-loaded bone cement and systemic antibiotic prophylactic use in 2,971,357 primary total knee arthroplasties from 2010 to 2020: an international register-based observational study among countries in Africa, Europe, North America, and Oceania
Background and purpose: Antibiotic-loaded bone cement (ALBC) and systemic antibiotic prophylaxis (SAP) have been used to reduce periprosthetic joint infection (PJI) rates. We investigated the use of ALBC and SAP in primary total knee arthroplasty (TKA).Patients and methods: This observational study is based on 2,971,357 primary TKAs reported in 2010–2020 to national/regional joint arthroplasty registries in Australia, Denmark, Finland, Germany, Italy, the Netherlands, New Zealand, Norway, Romania, South Africa, Sweden, Switzerland, the UK, and the USA. Aggregate-level data on trends and types of bone cement, antibiotic agents, and doses and duration of SAP used was extracted from participating registries.Results: ALBC was used in 77% of the TKAs with variation ranging from 100% in Norway to 31% in the USA. Palacos R+G was the most common (62%) ALBC type used. The primary antibiotic used in ALBC was gentamicin (94%). Use of ALBC in combination with SAP was common practice (77%). Cefazolin was the most common (32%) SAP agent. The doses and duration of SAP used varied from one single preoperative dosage as standard practice in Bolzano, Italy (98%) to 1-day 4 doses in Norway (83% of the 40,709 TKAs reported to the Norwegian arthroplasty register).Conclusion: The proportion of ALBC usage in primary TKA varies internationally, with gentamicin being the most common antibiotic. ALBC in combination with SAP was common practice, with cefazolin the most common SAP agent. The type of ALBC and type, dose, and duration of SAP varied among participating countries.
- Open Access
- 19 December 2022
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 17 (1) , 1-10
Information and BMI limits for patients with obesity eligible for knee arthroplasty: the Swedish surgeons’ perspective from a nationwide cross-sectional study
Background: In the past decades, the incidence of obesity has increased worldwide. This disease is often accompanied with several comorbidities and therefore, surgeons and anesthesiologists should be prepared to provide optimal management for these patients. The aim of this descriptive cross-sectional study was to map the criteria and routines that are used by Swedish knee arthroplasty surgeons today when considering patients with obesity for knee arthroplasty. Methods: A survey including 21 items was created and sent to all the Swedish centers performing knee arthroplasty. The survey included questions about the surgeons’ experience, hospital routines of preoperative information given and the surgeons’ individual assessment of patients with obesity that candidates for knee arthroplasty. Descriptive statistics were used to present the data. Results: A total of 203 (64%) knee surgeons responded to the questionnaire. Almost 90% of the surgeons claimed to inform their patients with obesity that obesity has been associated with an increased risk of complications after knee arthroplasty. Seventy-nine percent reported that they had an upper BMI limit to perform knee arthroplasty, a larger proportion of the private centers had a BMI limit compared to public centers. The majority of the centers had an upper BMI limit of 35. Conclusion: The majority of the knee arthroplasty surgeons in Sweden inform their patients with obesity regarding risks associated with knee arthroplasty. Most centers that perform knee arthroplasties in Sweden have an upper BMI limit.
- 19 December 2022
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 17 (1) , 1-10
Open AccessInformation and BMI limits for patients with obesity eligible for knee arthroplasty: the Swedish surgeons’ perspective from a nationwide cross-sectional study
Background: In the past decades, the incidence of obesity has increased worldwide. This disease is often accompanied with several comorbidities and therefore, surgeons and anesthesiologists should be prepared to provide optimal management for these patients. The aim of this descriptive cross-sectional study was to map the criteria and routines that are used by Swedish knee arthroplasty surgeons today when considering patients with obesity for knee arthroplasty. Methods: A survey including 21 items was created and sent to all the Swedish centers performing knee arthroplasty. The survey included questions about the surgeons’ experience, hospital routines of preoperative information given and the surgeons’ individual assessment of patients with obesity that candidates for knee arthroplasty. Descriptive statistics were used to present the data. Results: A total of 203 (64%) knee surgeons responded to the questionnaire. Almost 90% of the surgeons claimed to inform their patients with obesity that obesity has been associated with an increased risk of complications after knee arthroplasty. Seventy-nine percent reported that they had an upper BMI limit to perform knee arthroplasty, a larger proportion of the private centers had a BMI limit compared to public centers. The majority of the centers had an upper BMI limit of 35. Conclusion: The majority of the knee arthroplasty surgeons in Sweden inform their patients with obesity regarding risks associated with knee arthroplasty. Most centers that perform knee arthroplasties in Sweden have an upper BMI limit.
- Open Access
- 28 November 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 866–873
Impact of Nordic Arthroplasty Register Association (NARA) collaboration on demographics, methods and revision rates in knee arthroplasty: a register-based study from NARA 2000–2017
Background and purpose: We have previously observed differences in treatment and outcome of knee arthroplasties in the Nordic countries. To evaluate the impact of Nordic collaboration in the last 15 years we aimed to compare patient demographics, methods, and revision rates in primary knee arthroplasties among the 4 Nordic countries.Patients and methods: We included 535,051 primary knee arthroplasties reported 2000–2017 from the Nordic Arthroplasty Register Association (NARA) database. Kaplan–Meier analysis (KM) and restricted mean survival time (RMST) analysis were used to evaluate the cumulative revision rate (CRR) and RMST estimates with 95% confidence intervals (CI) and to compare countries in relation to risk of revision for any reason.Results: After 2010, the increase in incidence of knee arthroplasty plateaued in Sweden and Denmark but continued to increase in Finland and Norway. In 2017 the incidence was highest in Finland with 226 per 105 person-years, while it was less than 150 per 105 in the 3 other Nordic countries. In total knee arthroplasties performed for osteoarthritis (OA), overall CRR at 15 years for revision due to any reason was higher in Denmark (CRR 9.6%, 95% CI 9.2−10), Norway (CRR 9.1%, CI 8.7−9.5), and Finland (CRR 7.0%, CI 6.8−7.3) compared with Sweden (CRR 6.6%, CI 6.4−6.8). There were differences among the countries in use of implant brand and type, fixation, patellar component, and use of unicompartmental knee arthroplasty.Interpretation: We evinced a slowing growth of incidence of knee arthroplasties in the Nordic countries after 2010 with Finland having the highest incidence. We also noted substantial differences among the 4 Nordic countries, with Sweden having a lower risk of revision than the other countries. No impact of NARA could be demonstrated and CRR did not improve over time.
- 28 November 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 866–873
Open AccessImpact of Nordic Arthroplasty Register Association (NARA) collaboration on demographics, methods and revision rates in knee arthroplasty: a register-based study from NARA 2000–2017
Background and purpose: We have previously observed differences in treatment and outcome of knee arthroplasties in the Nordic countries. To evaluate the impact of Nordic collaboration in the last 15 years we aimed to compare patient demographics, methods, and revision rates in primary knee arthroplasties among the 4 Nordic countries.Patients and methods: We included 535,051 primary knee arthroplasties reported 2000–2017 from the Nordic Arthroplasty Register Association (NARA) database. Kaplan–Meier analysis (KM) and restricted mean survival time (RMST) analysis were used to evaluate the cumulative revision rate (CRR) and RMST estimates with 95% confidence intervals (CI) and to compare countries in relation to risk of revision for any reason.Results: After 2010, the increase in incidence of knee arthroplasty plateaued in Sweden and Denmark but continued to increase in Finland and Norway. In 2017 the incidence was highest in Finland with 226 per 105 person-years, while it was less than 150 per 105 in the 3 other Nordic countries. In total knee arthroplasties performed for osteoarthritis (OA), overall CRR at 15 years for revision due to any reason was higher in Denmark (CRR 9.6%, 95% CI 9.2−10), Norway (CRR 9.1%, CI 8.7−9.5), and Finland (CRR 7.0%, CI 6.8−7.3) compared with Sweden (CRR 6.6%, CI 6.4−6.8). There were differences among the countries in use of implant brand and type, fixation, patellar component, and use of unicompartmental knee arthroplasty.Interpretation: We evinced a slowing growth of incidence of knee arthroplasties in the Nordic countries after 2010 with Finland having the highest incidence. We also noted substantial differences among the 4 Nordic countries, with Sweden having a lower risk of revision than the other countries. No impact of NARA could be demonstrated and CRR did not improve over time.
- Open Access
- 15 July 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 682-683
Manipulation under anesthesia: to do or not to do, that is the question
- 15 July 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 682-683
Open AccessManipulation under anesthesia: to do or not to do, that is the question